0
0.5
1
1.5
2+
Mortality
-396%
Improvement
Relative Risk
Hospitalization
10%
Progression
6%
Conv. Plasma C3PO EARLY TREATMENT RCT
Is early treatment with convalescent plasma beneficial for COVID-19?
RCT 511 patients in the USA (August 2020 - February 2021)
Higher mortality with convalescent plasma (not stat. sig., p=0.22)
c19early.org
Korley et al., NEJM, August 2021
Favors conv. plasma
Favors control